Login to get immediate access to this content.
LoginSpeaker: Peter G. de Gooyer, Netherlands
Abstract discussed:
- 503O - Neoadjuvant nivolumab (nivo) plus relatlimab (rela) in MMR-deficient colon cancer: Results of the NICHE-3 study: Watch the presentation from ESMO 2024 now
The speakers and studies featured in this video series were selected independently by ESMO.
Published October 2024